methyl (S)-phenyl((R)-piperidin-2-yl)acetate → 1-Azabicyclo[4.2.0]octan-8-one

HRID 658333

반응식

HRID 658333 반응식
C[O:2][C:3]([CH:5](C1C=CC(Br)=CC=1)[CH:6]1[NH:11][CH2:10][CH2:9][CH2:8][CH2:7]1)=O.COC([C@@H](C1C=CC=CC=1)[C@@H]1NCCCC1)=O>>[N:11]12[C:3](=[O:2])[CH2:5][CH:6]1[CH2:7][CH2:8][CH2:9][CH2:10]2

참가 물질

3

실험 절차

Pan et al., Eur. J. Pharmacol., 264:177-182 (1994) (“Pan”) describes the synthesis of bromine-substituted methylphenidate analogs. In particular, Pan describes the synthesis of the o-bromo, m-bromo and p-bromo methylphenidate (bromo substitutents on the phenyl ring). The Panizzon synthesis of methylphenidate was modified to prepare p-bromomethylphenidate. Briefly, methylphenidate's molecular skeleton was prepared by base catalyzed reaction of p-bromophenylacetonitrile with o-chloropyridine. Following hydrolysis of the nitrile group to an amide, the pyridine ring was reduced to produce a 4:1 mixture of the erythro and threo isomers of ritalinic acid amide. Epimerization with NaOH, acid hydrolysis of the amide, and treatment with methanol/hydrogen chloride then gave dl-threo-p-bromo-methylphenidate hydrochloride in about 10% overall yield. An early batch used in in vivo experiments was about 85% pure due to the presence of erythro isomers of p-bromomethylphenidate and a trace of dl-threo-methylphenidate. These impurities were removed by several recrystallizations from methanol/ether before in vitro binding experiments were performed. Nuclear magnetic resonance (NMR) spectroscopic data were consistent with the assigned structure (δ3.26 doublet for the benzylic hydrogen showing the threo configuration; δ7.18 and 7.44 doublets for the aromatic protons) and a purity of >98%. Chiral high performance liquid chromatography (HPLC) using a Daicel 250×10 mm column eluted with hexane-isopropanol-diethylamine (98:2:0.1, v/v at 4 ml/min) showed two peaks of equal area at 10 and 12 minutes. The analogous o- and m-bromo derivatives were also prepared from the corresponding o- and m-bromophenylacetonitriles, and shown by NMR and chiral HPLC to be >95% pure.

후처리

  1. customThese impurities were removed by several recrystallizations from methanol/ether before in vitro binding experiments
  2. washeluted with hexane-isopropanol-diethylamine (98:2:0.1, v/v at 4 ml/min)
  3. customat 10 and 12 minutes
  4. customThe analogous o- and m-bromo derivatives were also prepared from the corresponding o- and m-bromophenylacetonitriles

출처 및 근거

ORD 기록
ord-4dbdf67283484512bd47d08da9393be4
출처 데이터셋
uspto-grants-2011_12
특허 번호
US08076485B2

연결된 노트

불러오는 중…